Monday, July 4, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Vaccinated mothers transfer SARS-CoV-2 antibodies to their breastfed infants

by Medical Finance
in Coronavirus
Vaccinated mothers transfer SARS-CoV-2 antibodies to their breastfed infants
10
SHARES
110
VIEWS
Share on FacebookShare on Twitter

Women vaccinated against COVID-19 transfer SARS-CoV-2 antibodies to their breastfed infants, potentially giving their babies passive immunity against the coronavirus, according to University of Massachusetts Amherst research.

The study, published in the journal Obstetrics & Gynecology, measured the immune response to the COVID-19 mRNA vaccine in both breast milk and the stools of breastfed infants.

This research is the first to detect SARS-CoV-2 antibodies in stool samples from infants of vaccinated mothers. This is really important because women want to know whether their babies have these antibodies, and our study shows that antibodies are being transferred via breast milk. Providing this compelling evidence is motivation for women to continue breastfeeding after they receive the vaccine.”


Vignesh Narayanaswamy, lead author, Ph.D. candidate in the breastmilk research lab of senior author Kathleen Arcaro, professor of environmental toxicology in the Department of Veterinary and Animal Sciences

Narayanaswamy notes another important takeaway: the antibodies were detected in infants regardless of age – from 1.5 months old to 23 months old.

Thirty lactating women from across the U.S. – most of them healthcare workers – were enrolled in the study. They received the COVID-19 mRNA vaccine between January and April 2021. The women provided breast milk samples before they were vaccinated, across two to three weeks after their first vaccine dose and across three weeks after the second dose. They also gave samples of their blood, spotted on cards, 19 days after the first dose and 21 days after the second dose. Infant stool samples were collected 21 days after the mothers’ second vaccination. Pre-pandemic samples of breast milk, dried blood spots and infant stools were used as controls for the study.

The samples were tested for receptor-binding domain (RBD)-specific immunoglobulin (Ig)A and IgG antibodies. In the breast milk samples, anti-RBD IgG antibodies were found to neutralize the protein spike of SARS-CoV-2, as well as four variants. A significant increase in cytokine levels also revealed the immune response in breast milk samples.

Anti-RBD IgG and anti-RBD IgA antibodies were detected in 33% and 30% of infant stool samples, respectively. The levels of antibodies correlated with the vaccine side effects the mother experienced.

“Women who did feel sick from the vaccine was associated with greater antibodies in the infant stool,” Arcaro says. “So you might have felt badly, but that was a benefit for your infant.”

The study, Arcaro says, received no specific funding and was partially driven by the participants themselves, who were familiar with Arcaro’s wide-ranging breast milk research, including the New Moms Wellness Study and BRCA gene-mutation research that Narayanaswamy focuses on.

While lactating and pregnant women were urged to be vaccinated, no pregnant or breastfeeding women were included in the vaccine trials, Arcaro notes. Findings show that “even if you had COVID, there is a benefit for women to get the vaccine.”

The research team included Arcaro’s UMass colleagues Dominique Alfandari, Brian Pentecost and Sallie Schneider; Dr. Corina Schoen, assistant professor of obstetrics and gynecology at UMass Chan Medical School-Baystate; and Ryan Baker, a UMass Amherst undergraduate student.

Source:

University of Massachusetts Amherst

Journal reference:

Narayanaswamy, V., et al. (2021) Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination. Obstetrics and Gynecology. doi.org/10.1097/AOG.0000000000004661.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant. Image Credit: Naeblys/Shutterstock

Neutralization potency against the Omicron variant of naturally expressed MBC-derived IgG antibodies from vaccinated individuals

by Medical Finance
July 4, 2022
0

In the recent paper published in the journal Immunity, researchers have shown how the Omicron (B.1.1.529) variant of the severe...

Study: Mental health assessment of Israeli adolescents before and during the COVID-19 pandemic. Image Credit: Alina Kruk/Shutterstock

Incidence rates of psychiatric diagnoses and drugs in Israeli adolescents before and during the COVID-19 pandemic

by Medical Finance
July 4, 2022
0

In a recent retrospective cohort study of mental health and wellbeing of adolescents posted to the medRxiv* preprint server,...

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

by Medical Finance
July 4, 2022
0

A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a...

Image Credit: In Silico Analysis Of The Effects Of Omicron Spike Amino Acid Changes On The Interactions With Human ACE2 Receptor And Structurally Characterized Complexes With Human Antibodies. Image Credit: Kateryna Kon/Shutterstock

Effects of the Omicron spike amino acid changes in the interaction with human ACE2 receptor or human antibodies

by Medical Finance
July 4, 2022
0

A recent study posted to the bioRxiv* pre-print server analyzed the effects of the interaction between severe acute respiratory...

Image Credit: Dkoi/Shutterstock.com

what we know so far

by Medical Finance
July 4, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern has spread rapidly since its emergence in...

Study: Vaccinating children against COVID-19: commentary and mathematical modelling. Image Credit: New Africa/Shutterstock

Mathematical modeling the vaccination of children against SARS-CoV-2

by Medical Finance
July 4, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers evaluated the safety of mRNA vaccination against severe...

Next Post
Using diffusion-weighted MRI to visualize brain inflammation in vivo for the first time

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

Study: Regulatory T-cells are central hubs for age-, sex- and severity-associated cellular networks during COVID-19. Image Credit: People Image Studio/Shutterstock

Mapping regulatory T-cell populations in COVID-19 patients

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Bounce backs amid continued losses: Life expectancy changes since COVID-19. Image Credit: eamesBot/Shutterstock
    Estimating life expectancy changes since 2020
  • Study: Green tea consumption and SARS-CoV-2 infection among staff of a referral hospital in Japan. Image Credit: grafvision/Shutterstock
    The association between green tea consumption and SARS-CoV-2 infection among Japanese
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply